↓ Skip to main content

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, February 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
63 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Published in
Journal for Immunotherapy of Cancer, February 2019
DOI 10.1186/s40425-019-0523-2
Pubmed ID
Authors

Mirjam Fässler, Stefan Diem, Joanna Mangana, Omar Hasan Ali, Fiamma Berner, David Bomze, Sandra Ring, Rebekka Niederer, Cristina del Carmen Gil Cruz, Christian Ivan Pérez Shibayama, Michal Krolik, Marco Siano, Markus Joerger, Mike Recher, Lorenz Risch, Sabine Güsewell, Martin Risch, Daniel E. Speiser, Burkhard Ludewig, Mitchell P. Levesque, Reinhard Dummer, Lukas Flatz

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 63 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 16%
Student > Master 9 14%
Researcher 6 10%
Professor 5 8%
Student > Bachelor 4 6%
Other 8 13%
Unknown 21 33%
Readers by discipline Count As %
Medicine and Dentistry 11 17%
Biochemistry, Genetics and Molecular Biology 9 14%
Immunology and Microbiology 7 11%
Agricultural and Biological Sciences 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 4 6%
Unknown 24 38%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2020.
All research outputs
#5,558,311
of 17,351,915 outputs
Outputs from Journal for Immunotherapy of Cancer
#957
of 1,739 outputs
Outputs of similar age
#108,863
of 274,161 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#1
of 1 outputs
Altmetric has tracked 17,351,915 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 1,739 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.7. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,161 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them